These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6299066)

  • 1. Recommended deproteinizing methods for plasma guanidino compound analysis by liquid chromatography.
    Hoshino T
    Adv Exp Med Biol; 1982; 153():391-400. PubMed ID: 6299066
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic renal failure and guanidino compounds].
    Kinoshita T
    Yakugaku Zasshi; 1997 Nov; 117(10-11):673-80. PubMed ID: 9414581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanidino compounds in uraemic dialysed patients.
    De Deyn P; Marescau B; Lornoy W; Becaus I; Lowenthal A
    Clin Chim Acta; 1986 Jun; 157(2):143-50. PubMed ID: 3719996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automatic system for the assay of guanidino compounds to assess uremic status and effect of hemodialysis.
    Nohara Y; Hanai T; Suzuki J; Matsumoto G; Iinuma F; Kubo H; Kinoshita T
    Chem Pharm Bull (Tokyo); 1998 Nov; 46(11):1844-5. PubMed ID: 9845964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative determination of guanidino compounds: the excellent preparation of biological samples.
    Ando A; Kikuchi T; Mikami H; Fujii M; Yoshihara K; Orita Y; Abe H
    Adv Exp Med Biol; 1982; 153():381-9. PubMed ID: 7164911
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prostaglandin metabolism in blood platelets and guanidine level in patients with chronic uremia].
    Komarnicki M; Pietrzak I; Zozulińska M; Czarnecki R; Antoniewicz K; Baczyk K
    Pol Arch Med Wewn; 1984 Nov; 72(5):243-7. PubMed ID: 6535143
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations.
    De Deyn PP; Robitaille P; Vanasse M; Qureshi IA; Marescau B
    Nephron; 1995; 69(4):411-7. PubMed ID: 7777105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperprolactinemia and guanidinosuccinic acid in chronic renal failure].
    Fujimura A; Kawato M; Nakabayashi H; Tofuku Y; Noto M; Akiyama T; Kido C; Kuroda M; Takeda R
    Nihon Jinzo Gakkai Shi; 1983 Feb; 25(2):199-204. PubMed ID: 6620688
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on guanidine compounds in uremia: reevaluation of serum GSA in relation to acute symptoms of uremia (author's transl)].
    Tofuku Y; Kuroda M; Kita T; Takeda R
    Nihon Jinzo Gakkai Shi; 1980 Mar; 22(3):249-58. PubMed ID: 7382166
    [No Abstract]   [Full Text] [Related]  

  • 10. [Guanidino compounds and aliphatic monoamines in acute and chronic renal failure].
    Suzuki Y
    Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1077-85. PubMed ID: 1289608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An automated technique for the analysis of plasma guanidino acids, and some findings in chronic renal disease.
    Shainkin R; Berkenstadt Y; Giat Y; Berlyne GM
    Clin Chim Acta; 1975 Apr; 60(1):45-50. PubMed ID: 236102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of methylguanidine and changes in guanidino compound levels in plasma, urine, and kidneys of furosemide-treated rats.
    Levillain O; Marescau B; Possemiers I; De Deyn PP
    Metabolism; 2008 Jun; 57(6):802-10. PubMed ID: 18502263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Platelet aggregation in chronic renal failure--whole blood aggregation and effect of guanidino compounds].
    Maejima M; Takahashi S; Hatano M
    Nihon Jinzo Gakkai Shi; 1991 Feb; 33(2):201-12. PubMed ID: 2051648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of methylguanidine analysis in clinical tests].
    Aoyagi K; Narita M
    Nihon Rinsho; 1989 Dec; 48 Suppl():432-5. PubMed ID: 2621917
    [No Abstract]   [Full Text] [Related]  

  • 15. Liquid-chromatographic determination of guanidino compounds in plasma and erythrocyte of normal persons and uremic patients.
    Kikuchi T; Orita Y; Ando A; Mikami H; Fujii M; Okada A; Abe H
    Clin Chem; 1981 Nov; 27(11):1899-902. PubMed ID: 7296840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Guanidino-succinic acid in uremic patients treated with periodic hemodialysis].
    Man NK; Rondon-Nucete M; Kamoun PP; Pleau JM; Zingraff J; Jungers P
    J Urol Nephrol (Paris); 1972 Sep; 78(9):750-5. PubMed ID: 4660657
    [No Abstract]   [Full Text] [Related]  

  • 17. High-performance liquid chromatographic analysis of guanidino compounds using ninhydrin reagent. II. Guanidino compounds in blood of patients on haemodialysis therapy.
    Hiraga Y; Kinoshita T
    J Chromatogr; 1985 Aug; 342(2):269-75. PubMed ID: 4055949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogenetic differences in convulsive action and cerebral uptake of uremic guanidino compounds in juvenile mice.
    D'Hooge R; Pei YQ; Marescau B; De Deyn PP
    Neurochem Int; 1994 Mar; 24(3):215-20. PubMed ID: 8025530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gas-liquid chromatographic measurement of guanidino acids.
    Patel H; Cohen BD
    Clin Chem; 1975 Jun; 21(7):838-43. PubMed ID: 1132134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective method for determination of methylguanidine in biological fluids. Its application in normal subjects and uremic patients.
    Eksborg S; Persson BA; Allgen LG; Bergström J; Zimmerman L; Fürst P
    Clin Chim Acta; 1978 Jan; 82(1-2):141-50. PubMed ID: 618677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.